BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26457976)

  • 1. A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report.
    Goodman DJ; Milliken CU; Theiler RN; Nordstrom BR; Akerman SC
    J Dual Diagn; 2015; 11(3-4):248-57. PubMed ID: 26457976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal buprenorphine treatment and infant outcome.
    Jansson LM; Velez ML; McConnell K; Spencer N; Tuten M; Jones H; Rios R; King VL; Gandotra N; Millio L; DiPietro JA
    Drug Alcohol Depend; 2017 Nov; 180():56-61. PubMed ID: 28869859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Perinatal Opioid Use Disorder.
    Boyars L; Guille C
    Obstet Gynecol Clin North Am; 2018 Sep; 45(3):511-524. PubMed ID: 30092925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient.
    Pan A; Zakowski M
    Clin Obstet Gynecol; 2017 Jun; 60(2):447-458. PubMed ID: 28426507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal Abstinence Syndrome: Presentation and Treatment Considerations.
    Jones HE; Kaltenbach K; Johnson E; Seashore C; Freeman E; Malloy E
    J Addict Med; 2016; 10(4):224-8. PubMed ID: 27244045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.
    Bandstra ES
    Addiction; 2012 Nov; 107 Suppl 1():1-4. PubMed ID: 23106922
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure.
    Nguyen L; Lander LR; O'Grady KE; Marshalek PJ; Schmidt A; Kelly AK; Jones HE
    Am J Addict; 2018 Mar; 27(2):92-96. PubMed ID: 29473258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine and Naloxone Versus Buprenorphine for Opioid Use Disorder in Pregnancy: A Cohort Study.
    Mullins N; Galvin SL; Ramage M; Gannon M; Lorenz K; Sager B; Coulson CC
    J Addict Med; 2020; 14(3):185-192. PubMed ID: 31567599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K; Morrone WR; O'Grady KE; Jones HE
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes.
    O'Connor A; Alto W; Musgrave K; Gibbons D; Llanto L; Holden S; Karnes J
    J Am Board Fam Med; 2011; 24(2):194-201. PubMed ID: 21383220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014.
    Brogly SB; Turner S; Lajkosz K; Davies G; Newman A; Johnson A; Dow K
    J Obstet Gynaecol Can; 2017 Mar; 39(3):157-165. PubMed ID: 28343557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing opioid dependence in pregnancy -- a general practice perspective.
    Arunogiri S; Foo L; Frei M; Lubman DI
    Aust Fam Physician; 2013 Oct; 42(10):713-6. PubMed ID: 24130973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
    Stitzer ML
    Addiction; 2013 Feb; 108(2):249-50. PubMed ID: 23331877
    [No Abstract]   [Full Text] [Related]  

  • 18. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Will My Baby Be OK?" A Qualitative Analysis of Pregnant Women's Suboxone
    Moore DJ; Butzlaff A
    J Am Psychiatr Nurses Assoc; 2023; 29(3):185-193. PubMed ID: 37038973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 23-year-old woman being treated for opioid dependence, unexpected weight gain.
    Chudgar NP; Greenblatt L
    J Fam Pract; 2014 Jul; 63(7):366-7. PubMed ID: 25198209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.